Skip to main content
PETNET Solutions to manufacture, distribute Zionexa's PET radiotracer

PETNET Solutions entered into an exclusive agreement with Zionexa to manufacture and distribute Zionexa's PET radiopharmaceutical fluoroestradiol. The FDA has yet to approve fluoroestradiol, which is approved in France for estrogen receptor status characterization in patients with metastatic breast cancer.

Full Story: